Displaying 1 - 4 of 4
Author:Radzik, Anne Marie Anderson, Annika Amezcua, Lilyana Ahmad, Sophie Brandstadter, Rachel Fabian, Michelle Graham, Edith Hodgkinson, Sophia Horton, Lindsay Jacobs, Dina Katz Sand, Ilana Kohli, Amit Okai, Annette McLemore, Monica Patel, Jasmin Poole, Shane Satyanarayan, Sammita Riley, Claire Tardo, Lauren Verter, Elizabeth Villacorta, Veronica Williams, Mitzi Zimmerman, Vanessa Zuroff, Leah Houtchens, Maria Bove, Riley
Session Name:S31: MS Clinical Decision Making and Special Populations
Topic:MS and Inflammatory Disease
Program Number:S31.002
Author Institution:University of California, San Francisco, Berkeley, CA University of Southern California, North Tustin, CA Northwestern University, Chicago, IL Hospital of the University of Pennsylvania, Philadelphia, PA Corinne Goldsmith Dickinson Center for MS, New York, NY Brigham and Women's Hospital , Boston, MA University of Texas Southwestern Medical Center, Dallas, TX North Texas Institute of Neurology and Headache, Plano, TX Columbia University Medical Center, New York, NY University of Southern California, Los Angeles, CA Joi Life Wellness Group, SMYRNA, GA
Author:Bernitsas, Evanthia Reder, Anthony Chinea, Angel Herrman, Craig O'Brien, Barbara Sater, Richard Amezcua, Lilyana Williams, Mitzi Wu, Gregory Vartanian, Timothy Pei, Jinglan Acosta, Juan Monson, Nancy
Session Name:S31: MS Clinical Decision Making and Special Populations
Topic:MS and Inflammatory Disease
Program Number:S31.006
Author Institution:Wayne State University School of Medicine, Detroit, MI University of Chicago Medicine, Oak Park, IL San Juan MS Center, San Juan, PR JWM Neurology, Indianapolis, IN Baptist Memorial Hospital-Collierville, Collierville, TN Cone Health Medical Group, Greensboro, NC Keck School of Medicine, University of Southern California, Los Angeles, CA Joi Life Wellness MS Center, Smyrna, GA Washington University in St Louis, St Louis, MO Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, NY Genentech, Inc., South San Francisco, CA University of Texas Southwestern, Dallas, TX
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
Author:Williams, Mitzi Krieger, Stephen Okai, Annette Gianatasio, Chloe Goldberg, Natalie Schmidt, Hollie Loud, Sara Minnis, Kasey Blake, Natalie Moss, Brian
Session Name:P9: MS Special Populations
Topic:MS and Inflammatory Disease
Program Number:P9.008
Author Institution:Joi Life Wellness Group, SMYRNA, GA Mount Sinai Dept of Neurology, New York, NY North Texas Institute of Neurology and Headache, Plano, TX EfficientCME, Fort Lauderdale, FL EfficientCME, Camas, WA Accelerated Cure Project, Waltham, MA Multiple Sclerosis Foundation, Fort Lauderdale, FL
Displaying 1 - 4 of 4